Sponsor:
Canadian Cancer Trials Group
Code:
NCT04161248
Conditions
Lymphoma, B-Cell
Eligibility Criteria
Sex: All
Age: 16 - 65
Healthy Volunteers: Not accepted
Interventions
Venetoclax
Rituximab Injection
Rituximab SC
Gemcitabine
Dexamethasone
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations